These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1975281)

  • 41. Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.
    Lutz S; Mura RA; Hippe HJ; Tiefenbacher C; Niroomand F
    Br J Pharmacol; 2003 Nov; 140(6):1019-26. PubMed ID: 14559858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A model for distinguishing between beta1-receptors which mediate a specific effect on the heart rate and those which mediate a positively inotropic effect.
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):381-3. PubMed ID: 19365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of cholinolytic and adrenergic blocking preparations on rat erythrocyte resistance to hypo-osmotic hemolysis].
    Petrov AN
    Biull Eksp Biol Med; 1978 Jan; 85(1):48-51. PubMed ID: 23878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional status of beta-2-adrenoceptor in isolated membranes of mature erythrocytes from patients with cirrhosis and oesophageal varices.
    Hernández FT; Zapater P; De-Madaria E; Palazón JM; Pascual S; Irurzun J; Such J; Perez-Mateo M; Horga JF
    Vascul Pharmacol; 2006 Jun; 44(6):464-8. PubMed ID: 16624626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The functional characteristics of the beta 2-adrenoreceptors on the isolated membranes and intact erythrocytes of rats].
    Smurova EA
    Ontogenez; 1994; 25(6):42-6. PubMed ID: 7777255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
    Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
    Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
    Agaev MM; Azizov VA
    Kardiologiia; 2003; 43(2):29-34. PubMed ID: 12891269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Contractile function of the myocardium and central hemodynamics in acute myocardial infarct patients after a single intravenous injection of adrenergic beta receptor blockaders].
    Sandrikov VA; Iakovlev VF; Seleznev MN; Maglakelidze TA
    Kardiologiia; 1986 Sep; 26(9):20-2. PubMed ID: 2878102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selection of optimal dose of beta-blocker treatment in myocardial infarction patients based on changes in synchronization between 0.1 Hz oscillations in heart rate and peripheral microcirculation.
    Kiselev AR; Gridnev VI; Prokhorov MD; Karavaev AS; Posnenkova OM; Ponomarenko VI; Bezruchko BP
    J Cardiovasc Med (Hagerstown); 2012 Aug; 13(8):491-8. PubMed ID: 22343262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta-Adrenergic blocking agents in the post-myocardial infarction patient.
    Goldstein S
    Arch Intern Med; 1979 Oct; 139(10):1089-90. PubMed ID: 39535
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of patients with myocardial infarct and hyperdynamic syndrome with propranolol].
    Golikov AP; Riabinin VA; Polumiskov VIu; Berestov AA
    Kardiologiia; 1983 Sep; 23(9):24-9. PubMed ID: 6645186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Combined treatment with selective beta1 adrenoblockaders and beta2 adrenostimulants in patients with myocardial infarction associated with chronic obstructive lung diseases].
    Akse'lrud MM; Ustinov AG; Tatarskiĭ AR; Zasimov AA; Godiaev MIa
    Kardiologiia; 1989 Jan; 29(1):78-83. PubMed ID: 2567367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [beta-Adrenoblockers: current approaches to use].
    Martsevich SIu
    Ter Arkh; 2002; 74(1):67-70. PubMed ID: 11878066
    [No Abstract]   [Full Text] [Related]  

  • 54. Perioperative use of beta-blockers: past, present, and future.
    Akhtar S; Barash PG
    Int Anesthesiol Clin; 2002; 40(2):133-57. PubMed ID: 11897941
    [No Abstract]   [Full Text] [Related]  

  • 55. On wisdom after the event.
    Senn S; Harrell F
    J Clin Epidemiol; 1997 Jul; 50(7):749-51. PubMed ID: 9253383
    [No Abstract]   [Full Text] [Related]  

  • 56. [The molecular cellular aspects in predicting the course of an acute myocardial infarct].
    Sviridova EV; Shchegoleva TIu; Bakhova LK; Vasil'ev IuM
    Kardiologiia; 1993; 33(11):58-60, 6. PubMed ID: 8145426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative efficacy of behavioral stress management versus propranolol in reducing psychophysiological reactivity in post-myocardial infarction patients.
    Gatchel RJ; Gaffney FA; Smith JE
    J Behav Med; 1986 Oct; 9(5):503-13. PubMed ID: 3540309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
    van der Stouwe JG; Boeddinghaus J; Mueller C
    Eur Heart J; 2022 Feb; 43(8):834-835. PubMed ID: 34023894
    [No Abstract]   [Full Text] [Related]  

  • 59. [Erythrocyte aggregation in nonsmokers, smokers and myocardial infarct patients].
    Boss N; Chmiel H; Kachel V; Ruhenstroth-Bauer G
    Blut; 1973 Sep; 27(3):191-5. PubMed ID: 4762004
    [No Abstract]   [Full Text] [Related]  

  • 60. [Two cases of subendocardial infarction associated with subacute thyroiditis].
    Yasuda M; Takeuchi M; Kondo M; Fujii M; Konishi T; Sugawa M; Hamada M; Nakano T; Takezawa H
    Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1347-52. PubMed ID: 6151576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.